1. The use of anthracycline antibody complexes for specific anti-tumor therapy;Pietersz;Targeted Diagn. Ther.,1988
2. Preclinical investigation of the antitumour effects of anti-CD-19-idarubicin immunoconjugates;Rowland;Cancer Immunol. Immunother.,1993
3. Antibody conjugates for the treatment of cancer;Pietersz;Immunol. Res.,1942
4. Selective enhancement of antitumor activity of N-acetyl meiphalan on conjugation to monoclonal antibodies;Smyth;Cancer Res.,1987
5. The antitumour activity of idarubicin-monoclonal antibody conjugates in a disseminated thymoma model;Smyth;Cancer Res.,1991